CENTESSA PHARMACEUTICALS PLC Payments for Restructuring
CENTESSA PHARMACEUTICALS PLC reported Payments for Restructuring of $28.39 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-03-31
- CENTESSA PHARMACEUTICALS PLC payments for restructuring for the quarter ending 2025-12-31 was $93.00K.
- CENTESSA PHARMACEUTICALS PLC payments for restructuring for the quarter ending 2025-09-30 was $872.00K.
- CENTESSA PHARMACEUTICALS PLC payments for restructuring for the quarter ending 2025-06-30 was $2.38M.
- CENTESSA PHARMACEUTICALS PLC payments for restructuring for the quarter ending 2025-03-31 was $25.04M.
- CENTESSA PHARMACEUTICALS PLC payments for restructuring for fiscal 2025 was $28.39M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2025-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $965.00K derived: sum of 2 quarters · filed 2026-03-31 | $3.35M derived: sum of 3 quarters · filed 2026-03-31 | $28.39M 10-K · filed 2026-03-31 |
| 2025-09-30 | $872.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.25M derived: sum of 2 quarters · filed 2025-11-05 | $28.29M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $27.42M 10-Q · filed 2025-08-12 | ||
| 2025-03-31 | $25.04M 10-Q · filed 2025-05-14 |